Trial intelligence / Profile preview

AJG555 (Movicol) in Pediatric Chronic Constipation

NCT02961556Phase 3Completed

Sponsor
EA Pharma Co., Ltd.
Start
Nov 2016
Primary completion
Jun 2017
Modality
Polymer-based Nanoparticles
Countries
1
01

Overview

A Phase 3 trial of polyethylene glycol in chronic constipation, sponsored by EA Pharma Co., Ltd.. Started Nov 2016; status: completed.

02

Drugs

polyethylene glycol
03

Conditions

chronic constipation

Beyond the preview

Go deeper on NCT02961556.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02961556.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call